May 2026: 0.78% (D- grade)

New Jersey inventionINDEX May 2026: 0.78% (D- grade)

The inventionINDEX measures innovation output by comparing GDP growth with patent production growth. 

Anything over C grade is positive sentiment; anything under C is negative outlook/sentiment. Using that sentiment, it is possible to observe trends over time, and also compare states/countries. In doing so, we can predict which states have the best chance to recover economically from the pandemic (or any other economic incident that may occur).

New Jersey inventionINDEX Scores – Last 12 months

The New Jersey inventionINDEX registered a score of 0.78% alongside a D- rating in May 2026, capturing a marginal improvement over April’s score of 0.76% but extending a broader period of economic deceleration. This current figure positions the state significantly below its 60-month historical average of approximately 0.93%. Looking back at the opening months of 2026, a brief resurgence to 0.93% in March offered a temporary glimpse of momentum, only to be immediately erased by consecutive sub-optimal marks. This defensive trend underscores an innovation ecosystem that is presently struggling to establish traction, marking a distinct cooling phase compared to the healthier performance cycles observed in previous years.

A comprehensive review of the historical data over the last five years reveals a narrative defined by isolated, short-lived spikes ambient to prolonged valleys of low commercial output. The undisputed pinnacle of New Jersey’s creative index occurred in August 2025, when the index achieved its maximum score of 1.47% and earned its sole A+ rating. In contrast, the absolute baseline nadir was reached in November 2024, with the score plummeting to a dismal 0.68% and receiving an F rating. The historical timeline demonstrates that while the state possesses the infrastructure to generate high-performing bursts of intellectual property development, it has fundamentally struggled to anchor them, frequently regressing into the D and F evaluation brackets.

Securing higher inventionINDEX scores and retaining premium grades yield highly transformative outcomes for the state’s economic profile. Elevated scores reflect a highly productive landscape for patent generation, intense entrepreneurial activity, and strong corporate investments in advanced research and development. Because New Jersey boasts a deep historical legacy in pharmaceuticals, biotechnology, and telecommunications, premium index ratings serve as an essential signal to global venture capital firms that the region remains a lucrative destination for tech-focused deployment. These prosperous intervals amplify investor confidence, pull world-class scientific minds into the state’s specialized workforce, and accelerate the transition of laboratory breakthroughs into profitable marketplace solutions.

Conversely, a prolonged descent into lower scores and failing grades carries severe, long-term negative implications for New Jersey’s regional competitiveness. When the index persistently stalls beneath the 1.00% threshold, it indicates systemic bottlenecks in the creative pipeline, dwindling financial backing for local startups, or a lack of agility in commercializing proprietary concepts. This pattern of suppressed innovation risks triggering a localized brain drain, motivating top-tier engineering and scientific talent to relocate to more dynamic tech ecosystems. Over time, failing grades compound into institutional capital flight and diminished regional productivity, making a structural stabilization of the state’s invention pipeline a matter of strategic urgency.

Discussion:

In May, the New Jersey inventionINDEX scored a negative sentiment which was lower than the previous year’s average but outperformed the downward trend for the year. This is similar to the prior 12 months, which experienced a slight downward trend. 

As the economy continues to stabilize in the post-pandemic era, it remains uncertain whether any backlog of applications still exists or if the department has returned to normal processing timelines. The inventionINDEX could also be affected by lingering consequences from the pandemic, such as company closures, reduced workforces, and limited R&D capabilities, which may still be impacting current operations.

Learn More:

Are you thinking of patenting any of your bright ideas? Did you know your research work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? To find out more, please check out our free online eligibility test.

Swanson Reed’s New Jersey office provides R&D tax credit consulting and advisory services to Newark, Jersey City, Paterson, Elizabeth, Edison, Woodbridge, Lakewood, Toms River, Hamilton, and Trenton.

Feel free to book a quick teleconference with one of R&D tax specialists if you would like to learn more about R&D tax credit opportunities.

Who We Are:

Swanson Reed is the largest Specialist R&D tax credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D tax credit consulting services to our clients. We have been exclusively providing R&D tax credit claim preparation and audit compliance solutions for over 30 years. 

Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs.  For more information please visit us at www.swansonreed.com/free-webinars or contact your usual Swanson Reed representative.